MPI Technology Now Available to Medical Researchers in Australia
By MedImaging International staff writers Posted on 17 Jan 2017 |
Image: Magnetic Particle Imaging (MPI) that shows perfusion in the brain of a rat (Photo courtesy of AXT).
Medical researchers in Australia now have access to a new imaging technology called Magnetic Particle Imaging (MPI) that can give researchers improved insight into organ and tissue function, with sensitivity comparable to that of nuclear medicine, the speed of Computed Tomography (CT), and the resolution of Magnetic Resolution Imaging (MRI).
MPI provides improved sensitivity, resolution, and contrast over existing imaging technologies, by using Super Paramagentic Iron Oxide (SPiO) nanoparticles to tag cells anywhere in the body, at any tissue depth. MPI enables researchers to quantify what is actually happening in real time, and in vivo. In addition, MPI does not expose patients to ionizing radiation.
The new technology was part of a partnership agreement between AXT and Magnetic Insights. Momentum, the first MPI system can be used to generate quantitative images that analyze functional responses to drugs and treatments, in oncology, immunology, vascular function, and stem cell research, amongst others. The MPI technology could be used in the future to enable early detection and monitoring of neurovascular diseases such as stroke.
CEO of Magnetic Insight, Dr. Anna Christensen, said, “We are changing the landscape of diagnostic imaging with the impact of what MRI, PET and CT offered over 30 years ago. MPI complements many of the existing imaging modalities but also provides researchers and doctors levels of information that were not previously possible, all without radiation. We look forward to working with the team at AXT to bring this technology to Australia.”
MPI provides improved sensitivity, resolution, and contrast over existing imaging technologies, by using Super Paramagentic Iron Oxide (SPiO) nanoparticles to tag cells anywhere in the body, at any tissue depth. MPI enables researchers to quantify what is actually happening in real time, and in vivo. In addition, MPI does not expose patients to ionizing radiation.
The new technology was part of a partnership agreement between AXT and Magnetic Insights. Momentum, the first MPI system can be used to generate quantitative images that analyze functional responses to drugs and treatments, in oncology, immunology, vascular function, and stem cell research, amongst others. The MPI technology could be used in the future to enable early detection and monitoring of neurovascular diseases such as stroke.
CEO of Magnetic Insight, Dr. Anna Christensen, said, “We are changing the landscape of diagnostic imaging with the impact of what MRI, PET and CT offered over 30 years ago. MPI complements many of the existing imaging modalities but also provides researchers and doctors levels of information that were not previously possible, all without radiation. We look forward to working with the team at AXT to bring this technology to Australia.”
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer